Counting on Europe
14-10-2026
NEXXAHEALTH MAGAZINE - Bayer built the cell and gene therapy toolbox. Now Europe has to decide whether to pay for it. Read more
"If there will not be someone willing to pay for the innovation, then the next round of innovation will not be possible." - Tomer Feffer, Head of Region Northeast-Central Europe, Bayer / Photo: Bayer